# FDA Inspection 614862 - Novo Nordisk Inc. - September 28, 2009

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/1fdb1e45-cc76-4999-a3a5-00a97bce32f4
Source feed: FDA_Inspections

> FDA Inspection 614862 for Novo Nordisk Inc. on September 28, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 614862
- Company Name: Novo Nordisk Inc.
- Inspection Date: 2009-09-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1255957 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/38330e07-dc29-4eb1-b194-25515448e660)
- [FDA Inspection 1255957 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/db492566-9b2c-498b-81f8-e95e929b2d49)
- [FDA Inspection 1255957 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/b68c3a3c-5d39-4d5e-b050-802a21bd26f0)
- [FDA Inspection 1194065 - 2022-12-21](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/0dcc2982-f697-4dd2-98e6-769e21d4f06a)
- [FDA Inspection 1013344 - 2017-04-13](https://www.keypedia.com/records/fda_inspections/novo-nordisk-inc/1d5c8257-f349-440a-9ebf-72db3b05a4f4)

Company: https://www.keypedia.com/companies/novo-nordisk-inc/920bb4ea-9450-45a6-bcd7-9f85c2f2bbad

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c